David Risinger's
Stock Forecasts
23.08%
3/13 win trades
Price targets by David Risinger
| Company name & ticker | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|
 Theravance Biopharma, Inc. TBPH | 11 months ago | $10 -25.65% downside | $7.66 | StreetInsider | Previous targets (0) |
 Vaxcyte, Inc. PCVX | 11 months ago | $135 325.46% upside | $106.74 | StreetInsider | |
 AnaptysBio, Inc. ANAB | 11 months ago | $45 127.38% upside | $19.38 | StreetInsider | |
 Roivant Sciences Ltd. ROIV | 11 months ago | $17 42.85% upside | $11.92 | StreetInsider | Previous targets (0) |
 Regeneron Pharmaceuticals, Inc. REGN | about 1 year ago | $1,077 87.37% upside | $1,091.98 | TheFly | Previous targets (0) |
 Bristol-Myers Squibb Company BMY | almost 2 years ago | $66 36.53% upside | $56.25 | Benzinga | Previous targets (0) |
Other analysts covering same stocks
Daniel Busby
RBC Capital
100%
win rate
Luisa Hector
Berenberg Bank
100%
win rate
Covering:
Tobias Gottschalt
Independent Research
100%
win rate
Covering:
Geoff Porges
Leerink Partners
100%
win rate
Navin Jacob
UBS
75%
win rate
Thomas Yeh
Morgan Stanley
75%
win rate
Steve Scala
Cowen & Co.
66.67%
win rate
Steve Chesney
Atlantic Equities
60%
win rate
Justin Smith
Societe Generale
50%
win rate
Tyler Van Buren
Cowen & Co.
50%
win rate